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Abstract
Objective: We  aimed  to  prospectively  evaluate  the  association  of  oral  microbiome  with  malignant  esophageal
lesions and its predictive potential as a biomarker of risk.
Methods: We conducted a case-control study nested within a population-based cohort with up to 8 visits of oral
swab collection for each subject over an 11-year period in a high-risk area for esophageal cancer in China. The oral
microbiome was evaluated with 16S ribosomal RNA (rRNA) gene sequencing in 428 pre-diagnostic oral specimens
from  84  cases  with  esophageal  lesions  of  severe  squamous  dysplasia  and  above  (SDA)  and  168  matched  healthy
controls. DESeq analysis was performed to identify taxa of differential abundance. Differential oral species together
with  subject  characteristics  were  evaluated  for  their  potential  in  predicting  SDA risk  by  constructing  conditional
logistic regression models.
Results: A total of 125 taxa including 37 named species showed significantly different abundance between SDA
cases and controls (all  P<0.05 & false discovery rate-adjusted Q<0.10).  A multivariate logistic model including 11
SDA lesion-related species and family history of esophageal cancer provided an area under the receiver operating
characteristic  curve (AUC) of  0.89 (95% CI,  0.84−0.93).  Cross-validation and sensitivity  analysis,  excluding cases
diagnosed within 1 year of collection of the baseline specimen and their matched controls, or restriction to screen-
endoscopic-detected  or  clinically  diagnosed  case-control  triads,  or  using  only  bacterial  data  measured  at  the
baseline, yielded AUCs>0.84.
Conclusions: The oral microbiome may play an etiological and predictive role in esophageal cancer, and it holds
promise as a non-invasive early warning biomarker for risk stratification for esophageal cancer screening programs.
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Introduction
Esophageal  cancer  is  the  seventh  most  common  cancer
worldwide  (1).  Fifty-five  percent  of  new  cases  occur
annually  in  China,  and  90%  of  these  are  esophageal
squamous cell carcinoma (ESCC) (2). Tobacco and alcohol
consumption  are  well-established  risk  factors  for
esophageal cancer in western countries, but contribute little
to  ESCC  incidence  in  high-risk  areas  such  as  Anyang  of
China  (2).  The  etiology  of  ESCC  needs  to  be  further
investigated  (2).  Most  ESCC  cases  are  diagnosed  at  an
advanced  stage  which  confers  an  unfavorable  prognosis.
Early  detection  has  been  shown  to  improve  survival  and
reduce  mortality  from  the  disease  (2),  with  upper
gastrointestinal  endoscopic  screening  being  widely
accepted  as  an  optimal  secondary  prevention  strategy  for
esophageal  lesions  of  severe  dysplasia  and  above  (SDA),
including  severe  squamous  dysplasia,  carcinoma in  situ
(CIS),  and ESCC, in  high-risk  populations.  However,  this
approach  has  disadvantages  such  as  its  potential  for
complications  (3).  Identification of  high-risk  individuals  in
the  general  population  through  the  use  of  minimally-
invasive biomarkers could help to maximize the benefits of
endoscopic  screening  by  targeting  those  most  likely  to
benefit.
Emerging evidence has linked the human microbiome
with  diseases  such  as  cancer.  The  development  of
microbiome-based risk prediction models for some types of
cancer, such as colorectal cancer, has opened new research
avenues, by demonstrating that the microbiome may be a
valid non-invasive biomarker of risk (4,5). Oral bacteria, in
particular periodontal pathogens, together with indicators
of oral health (e.g., tooth loss) have been reported to be
associated with ESCC and its precursor lesions (2,6,7). The
anatomic  proximity  of  the  esophagus  to  the  oral  cavity
likely renders the esophagus vulnerable to the effects of
oral  dysbiosis  (8).  We  thus  hypothesized  that  the  oral
microbiome is associated with the risk of developing SDA
lesions and thus may be useful as a non-invasive biomarker
of  risk  for  SDA lesions.  Only  a  few studies  have  so  far
characterized  the  oral  microbiome  in  SDA lesions  and
interpretation of their findings has been hampered by the
fact they relied on a single measurement taken from a one-
off oral specimen collection, did not use optimal methods
of statistical analysis for differential comparison of taxa, and
did not evaluate the predictive value of oral bacteria (7,9).
Given  the  dynamics  of  the  human  microbiome  (5),
prospective  follow-up  studies  with  repeat  specimen
sampling are warranted to better understand the role of
oral microbiome in malignant esophageal lesions.
The  present  case-control  study,  nested  within  a
population-based cohort in a high-risk area for esophageal
cancer in rural China with collection of multiple (up to 8)
oral swabs over an 11-year follow-up period (10,11), aims
to assess the association between oral microbiome and the
risk of  esophageal  SDA and to investigate the potential
value of this biomarker in predicting risk.
Materials and methods
Study design and participants
The  subjects  for  this  nested  case-control  study  were
selected from the prospective population-based endoscopic
Anyang Esophageal Cancer Cohort Study (AECCS; 9,035)
and  its  oral  sub-cohort  (4,073)  in  rural  Anyang,  China,  as
previously  described  (10,11).  Eligible  participants  (i.e.
permanent  residents  in  cluster-sampled  villages,  aged
25−65 years, with no prior history of cancer, cardiovascular
illness,  or  infection  with  Hepatitis  B,  Hepatitis  C,  or
Human  Immunodeficiency  Viruses)  were  visited  in  their
villages a maximum of 8 times for collection of oral  swabs
including  3  visits  at  2.5-year  intervals  from  2006  to  2013
(endoscopic  inspection  of  the  esophagus  was  also
performed at each visit), and 5 bi-annual visits from 2013 to
2015 (Figure 1).
Cases and controls were selected from AECCS who had
provided a baseline oral swab at enrollment into the cohort
(Figure 1). Cases included both screen-endoscopic-detected
SDA cases and clinically diagnosed SDA cases diagnosed
after collection of the baseline oral swab, but prior to July
2017, when follow-up of the cohort for the present analysis
ended. The clinically diagnosed SDA cases were identified
through annual active door-to-door interviews and through
passive  linkage  with  claims  data  from  the  New  Rural
Cooperative Medical Scheme. For each case, two controls
were randomly selected among cohort members who did
not  have  SDA  at  the  time  of  diagnosis  of  the  case
(incidence density sampling) matching on gender, village of
residence,  age  at  cohort  entry  (5-year  intervals),  and
number and timing (±1-year) of oral swab collection and
endoscopic examination.
The follow-up time for the included cases and controls
was estimated from time of enrolment into the cohort to
the time of a SDA diagnosis for cases, and corresponding
time for their two matched controls. The median follow-up
time was calculated by using the reversed Kaplan-Meier
method (12).
The  study  was  performed  in  accordance  with  the
Declaration of Helsinki. Research protocols were approved
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Figure 1 SDA cases and their oral specimens used in this nested case-control study from Anyang, China, 2006−2017. (A) Visual overview of
SDA  cases  taken  from  the  prospective  AECCS  cohort  and  its  oral  sub-cohort  (Primary  outcome:  SDA  lesions).  C  denotes  clinically
diagnosed SDA cases (32 cases) which were identified by active follow-up. Interval SDA cases “C71, C72, C73...C7n” occurred sequentially
at interval 8 from the 7th follow-up to July 1st, 2017. S denotes screen-endoscopic-detected SDA cases (52 cases) diagnosed by endoscopy.
Screened SDA cases “S21, S22, S23...S2n” were diagnosed sequentially at the 2nd follow-up; (B) Number and time frame of oral specimen
collection  for  84  SDA  cases.  Points  are  plotted  according  to  years  of  oral  specimen  collection  prior  to  diagnosis  of  SDA  lesions.  Color
indicates  cross-sections  at  which  specimens  were  collected.  AECCS,  Anyang  Esophageal  Cancer  Cohort  Study;  ESOE,  endoscopic
screening of esophagus; FLWUP, follow-up; No., number; OSC, oral swab collection; SDA, severe dysplasia and above; Yr., year.
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by the Institutional Review Board of the Peking University
Cancer  Hospital  &  Institute.  All  participants  provided
written informed consent.
Oral specimen and questionnaire data collection
Using  saline-moistened  cotton  swabs,  exfoliated  oral  cells
were collected from the upper and lower lips, left and right
sides of the hard palate, the buccal mucosa, the top and the
bottom of the tongue, and the surface of the gingiva. Cells
were rinsed with 0.9% saline solution and frozen at −80 ℃
pending testing after centrifugation (10,11).  A total  of 143
pre-diagnosis oral specimens were provided by the 84 cases
(48 cases  provided only  one specimen;  26  provided two;  6
provided three; and 4 provided five or more specimens). Of
these 143 specimens, 49 were collected within 15 d before
the diagnosis of the SDA lesion, which were all provided by
screen-endoscopic-detected SDA cases (Figure 1).
A one-on-one computer-aided interview on demographic
characteristics  and potential  risk  factors  for  esophageal
cancer  (~50  items)  was  administered  by  a  trained
interviewer at the baseline visit  conducted at enrolment
into the cohort.
Laboratory handling and bioinformatics
DNA  was  extracted  using  the  E.Z.N.A.  Mag-Bind  Tissue
DNA Kit (Omega Bio-Tek, Inc., Norcross, USA). The 16S
ribosomal  (rRNA)  gene  V3−V4  regions  were  amplified
using  universal  primers  (341F  5’-CCTAYGGGRBGCA
SCAG-3’  and  806R  5’-GGACTACNNGGGTATCTA
AT-3’)  and  sequenced  on  the  Ion  S5  XL  sequencing
platform.
Multiplexed and barcoded sequences were deconvoluted.
High-quality  sequences were obtained according to the
Cutadapt  (V1.9.1)  quality-controlled  process.  Chimera
sequences were detected using the UCHIME algorithm
and then removed. Filtered sequence reads were clustered
into operational taxonomic units (OTUs). OTUs with a
mean relative abundance ≥0.001% were assigned to taxa
using the expanded Human Oral  Microbiome Database
(eHOMD) with ≥97% sequence similarity. From 428 oral
specimens (143 from cases; 285 from controls), we obtained
32,917,908  ( ,  76,911±10,444)  high-quality  sequence
reads, with similar numbers of reads per specimen for both
case and control groups (Supplementary Table S1). A total of
15 phyla, 44 classes, 79 orders, 147 families, 324 genera,
and  720  species  were  identified  and  included  in  our
analysis.
Quality control
Specimens from any given case-control triad were included
in the same batch and tested blindly. Ten replicate aliquots
of  oral  cell  DNA  from  eight  volunteers  were  mixed  and
included  in  the  5  sequencing  batches  (2  replicates  per
batch) as quality control samples. The intra-plate and inter-
plate  coefficients  of  variation  (CV)  for  the  Shannon
diversity  index  and observed-species  of  the  quality  control
samples  were  all  <7.0%  (Supplementary  Table  S2).
Rarefaction  curves  and  the  species-accumulation  boxplot
indicate  sufficient  sequence  depth  and  adequate  sample
size, respectively (Supplementary Figure S1,S2).
Statistical analysis
Dataset description
To obtain stable measurements of bacterial populations and
to account  for  heterogeneity  in  the  number  and timing of
specimens  from  different  subjects,  a  full  averaged  dataset
was  produced  for  bacterial  abundance  comparison  and
prediction  model  establishment.  This  dataset  contained  a
total  of  84  SDA  cases  providing  143  oral  specimens  and
168  matched  controls  providing  285  oral  specimens
(Figure  1).  The  bacterial  population  values  for  each
specimen  provided  by  an  individual  were  averaged  to
produce  single  values  at  each  taxonomic  level  (e.g.,  class,
species) for that individual.
Overall diversity comparison
Trends of α diversity (Shannon index) with years of specimen
collection  prior  to  diagnosis  of  malignant  esophageal
lesions  were  evaluated  using  linear  mixed-effects  (LME)
regression (LME function in R) by treating the subject as a
random effect. Differences in α diversity between cases and
controls  were  also  analyzed  by  LME  regression.
Differences  in overall  bacterial  community composition (β
diversity) according to case and control status were assessed
with  permutational  multivariate  analysis  of  variance
(PERMANOVA; adonis function in R) by treating matched
case-control triads as strata.
Association analysis
To  compare  relative  abundance  of  taxa  in  SDA  cases  and
controls at each level (phylum to species), DESeq (DESeq2
package,  R)  with  variance  and  mean  linked  by  local
multivariable  regression,  which  is  an  optimal  method  for
microbiome data analysis, was performed based on the full
averaged  dataset  (13,14).  Taxa  were  considered
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significantly  differentially  abundant  between  groups  if
P<0.05 & the false discovery rate (FDR)-adjusted Q<0.10.
Prediction analysis
To  establish  a  final  prediction  model  for  risk  of  SDA
lesions  and determine  which  species  should  be  retained in
the  final  prediction  model,  analysis  was  carried  out  based
on  the  full  averaged  dataset  as  follows  (Supplementary
Figure S3). For each of the named and cultured differential
species  selected  by  DESeq  analysis,  multiple  species-
specific  classifiers  (low  carriage vs. high  carriage),  derived
from a series of cut-off points ranging from quantiles 5% to
95% (5% per step) of the relative abundance in the control
group,  were  evaluated  in  separate  univariate  conditional
logistic  regression  models  (dependent  variable:  SDA
status).  Taking  both  error  probability  and  effect  size  into
consideration,  the  optimal  classifiers  for  each  species  with
the lowest sum of odds ratio rank and reverse P value rank,
together  with  subject  characteristics  were  included  in  the
multivariate  conditional  logistic  model.  Their  retention  in
the final prediction model was determined using the Akaike
information  criterion  (step  AIC  function,  MASS  package,
R).  The  area  under  the  receiver  operating  characteristic
curve (AUC) and the DeLong test were adopted to evaluate
the performance of the prediction model. Leave-one triad-
out cross-validation was used to estimate the generalization
error  on the basis  of  predicted probabilities  for  each case-
control triad from models built on all the remaining triads.
Temporal stability assessment
To assess the temporal stability of the relative abundance of
oral  species  within  and  between  individuals,  we  used  the
metrics  of  mean,  standard  deviation,  and  CV as  employed
by Utter et al (15). A total of 128 specimens provided from
10  cases  and  18  controls  (each  with  three  or  more  serial
specimens) were included in this analysis. For each species,
means  and  CVs  for  each  individual  were  calculated  based
on the relative abundance of three or more specimens from
this individual. The mean CV (intra-individual CV) was the
mean  of  all  the  CVs  calculated  from  all  included
individuals;  the  overall  CV  was  calculated  based  on  the
relative  abundances  from  all  specimens  provided  by  all
included individuals.
Sensitivity analysis
To reduce the likelihood of reverse causation, the following
sensitivity analyses were performed: 1) including only cases
diagnosed more than 1 year after collection of the baseline
specimen and their matched controls, but using the average
microbiome  data  from  all  their  collected  oral  specimens
(strictly  averaged  dataset;  55  cases  with  87  specimens  and
110 controls with 176 specimens); 2) including all enrolled
study subjects,  but  using only  microbiome data  from their
oral  specimens  collected  at  baseline  (full  baseline  dataset;
84  cases  and  168  controls,  each  with  a  single  baseline
specimen); and 3) including only cases diagnosed more than
1  year  after  collection  of  the  baseline  specimen  and  their
matched  controls,  and  using  only  microbiome  data  from
their  oral  specimens  collected  at  baseline  (strict  baseline
dataset;  55  cases  and  110  controls,  each  with  a  single
baseline specimen). Also, stratified analysis was carried out
by  separating  screen-endoscopic-detected  and  clinically
diagnosed case-control triads. Model performance was also
recalculated  using  75th  quantile  cut-off  points  instead  of
optimal thresholds for classification of low vs. high carriage
of the predictive bacteria.
All multivariate models included level of education, type
of employment, cigarette smoking, alcohol consumption,
and family history of esophageal cancer unless otherwise
specified. All  analysis  was carried out using R statistical
software  (Version  3.4.3;  R  Foundation  for  Statistical
Computing, Vienna, Austria). P values less than 0.05 (two-
sided) were considered to be statistically significant.
Results
Participant characteristics
Median  follow-up  time  for  study  participants  was  of  8.7
(interquartile  range:  5.2−9.7)  years.  Cases  and  controls
were  of  a  similar  age  and  gender  (matching  variables)  and
had  a  similar  educational  level,  type  of  employment,  and
cigarette  smoking  and  alcohol  intake  habits.  Cases  were,
however, more likely to have a family history of esophageal
cancer than controls (15.5% vs. 7.1%, P=0.037) (Table 1).
Overall  microbiome  diversity  in  relation  to  malignant
esophageal lesions
No significant trend over years of specimen collection prior
to  diagnosis  of  malignant  esophageal  lesions  in  the
Shannon diversity index was found for SDA cases (P=0.124)
or  controls  (P=0.425)  (Supplementary  Figure  S4).  Between
groups,  cases  showed  a  slightly  higher  Shannon  diversity
index  than  controls  (P=0.044).  Cases  differed  significantly
from  controls  in  overall  oral  microbiome  composition  (β
diversity) neither when measured by unweighted (P=0.248)
nor  when  measured  by  weighted  UniFrac  distances
(P=0.590) (Supplementary Figure S4).
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Taxa associated with malignant esophageal lesions
Based  on  DESeq  analysis,  a  higher  abundance  of  15  taxa
including  6  species  was  found  to  be  associated  with
decreased  risk  of  SDA lesions,  and  a  higher  abundance  of
110 taxa including 66 species was associated with increased
risk  of  SDA  lesions  (all  P<0.05  &  Q<0.10).  Of  the  72
species  with  differential  abundance  between  cases  and
controls,  37  were  named  and  cultured  according  to
eHOMD  (Figure  2; Supplementary  Table  S3).  The  species
Fusobacterium nucleatum which is known to be associated
with  periodontal  diseases  (16,17),  and  all  of  its  higher
taxonomic  levels  were  among the  above  taxa  with  positive
associations.
Species-level  prediction  model  for  malignant  esophageal
lesions
A total of 11 species of 37 named and cultured differential
species  selected  by  DESeq  analysis,  together  with  family
history  of  esophageal  cancer  were  retained  in  the  final
model  predicting  risk  of  SDA  lesions.  These  species  and
their  corresponding  optimal  cut-off  points  for  relative
abundance  are  shown  in Table  2.  Higher  carriage  of  the
predictive species was associated with increased risk of SDA
lesions,  with  adjusted  ORs  ranging  from  1.98  (Prevotella
baroniae)  to  10.93  (Lachnoanaerobaculum umeaense).  For
Fusobacterium nucleatum, the adjusted OR was 3.85 (95%
CI, 1.12−13.24).
The AUC was 0.89 (95% CI, 0.84−0.93) for the final
model, which was constructed based on the full averaged
dataset  (Figure  3).  Leave-one triad-out  cross-validation
provided  similar  AUC  statistics  (AUC,  0.89;  95%  CI,
0.88−0.89). After exclusion of cases which were diagnosed
within 1 year of collection of the baseline specimen and
matched controls for these cases, the AUCstrictly averaged dataset
was 0.85 (95% CI, 0.80−0.91). When stratifying by case
type, the AUC for screen-endoscopic-detected cases and
matched controls was 0.90 (95% CI, 0.86−0.95) and the
AUC  for  clinically  diagnosed  SDA  cases  and  matched
controls  was  0.88  (95% CI,  0.81−0.94)  (Supplementary
Table 1 Selected demographic and baseline behavioral characteristics of cases of malignant esophageal lesions and matched controls from
Anyang, China, 2006−2017
Variables* Cases (N=84)** Controls (N=168)## P***
Age (IQR) (year) 57 (51−61) 56 (51−61) 0.140
Gender NA
　Female 40 (47.6) 80 (47.6)
　Male 44 (52.4) 88 (52.4)
Education level 0.520
　Primary school (1−6 years) or below 53 (63.1) 100 (59.5)
　Junior high school (7−9 years) or above 31 (36.9) 68 (40.5)
Type of employment 0.680
　Farming 66 (78.6) 135 (80.4)
　Non-farming 18 (21.4) 33 (19.6)
Cigarette smoking* 0.890
　No 53 (63.1) 105 (62.5)
　Yes 31 (36.9) 63 (37.5)
Alcohol consumption# 0.300
　No 72 (85.7) 136 (81.0)
　Yes 12 (14.3) 32 (19.0)
Family history of esophageal cancer 0.037
　No 71 (84.5) 156 (92.9)
　Yes 13 (15.5) 12 (7.1)
IQR, interquartile range; NA, not applicable; SDA, severe dysplasia and above; *, Cigarette smoking is defined as consumption of
one cigarette or more per day for at least 12 months; #, Alcohol consumption is defined as consumption of Chinese liquor twice per
week or more for at least 12 months; **, Cases were subjects with esophageal lesions of severe dysplasia and above (SDA) including
severe squamous dysplasia, carcinoma in situ, and esophageal squamous cell carcinoma; ##, Controls were subjects without SDA
lesions. ***, P values were calculated by univariate conditional logistic regression analyses.
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Figure  S5).  Additionally,  when  analysis  was  limited  to
baseline specimens, the AUCs were also similar [AUCfull
baseline dataset: 0.84 (95% CI, 0.79−0.89); AUCstrict baseline dataset:
0.85 (95% CI, 0.79−0.91)]. When the 75th quantile was
used as the cut-off point, the AUCs remained above 0.78
(Supplementary Figure S6).
Temporal stability of predictive species
For  the  11  predictive  species,  shifts  in  the  relative
abundance  over  time  (~8  years)  within  a  single  individual
 
Figure 2 Phylogenetic tree of taxa associated with malignant esophageal lesions. A total of 125 taxa including 72 species (marked by colorful
bars around the phylogenetic tree) was found to be associated with risk of SDA lesions (all P<0.05 & FDR-adjusted Q<0.10). Among these
72  species,  37  of  them  were  named  and  cultured  according  to  eHOMD  (marked  with  species  names  in  the  Figure).  The  species
Fusobacterium nucleatum which is  known to be associated with periodontal  diseases,  and all  of  its  higher taxonomic levels  (marked in the
green area of the Figure) were among the above taxa with positive associations. (P), (C), (O), (F), and (G) indicate bacterial taxa at the level
of Phylum, Class, Order, Family, and Genus.
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were  generally  fluctuations  around  an  individual  mean,
which  did  not  exhibit  any  increasing  or  decreasing  trend
(Supplementary  Figure  S7).  These  species  had  lower  intra-
individual  CVs  within  each  subject  (average  of  intra-
individual  CVs=107.9%)  than  overall  CVs  across  all
specimens  provided  by  all  included  subjects  with  multiple
Table 2 Structure and OR of oral  microbiome-based prediction model for risk of malignant esophageal  lesions in Anyang, China,
2006−2017
Predictive species*
n (%)** OR (95% CI)***
Cases (N=84) Controls (N=168) Univariate Multivariate
Actinomyces odontolyticus
　Low carriage [<90% quantile (0.3677%)] 65 (77.4) 151 (89.9) Ref. Ref.
　High carriage [≥90% quantile (0.3677%)] 19 (22.6) 17 (10.1) 2.58 (1.25−5.29) 2.16 (0.80−5.88)
Actinomyces viscosus
　Low carriage [<95% quantile (1.5110%)] 72 (85.7) 159 (94.6) Ref. Ref.
　High carriage [≥95% quantile (1.5110%)] 12 (14.3) 9 (5.4) 3.74 (1.29−10.89) 7.70 (1.75−33.87)
Dialister invisus
　Low carriage [<75% quantile (0.0655%)] 49 (58.3) 126 (75.0) Ref. Ref.
　High carriage [≥75% quantile (0.0655%)] 35 (41.7) 42 (25.0) 2.43 (1.31−4.51) 2.32 (1.02−5.30)
Fusobacterium mortiferum
　Low carriage [<80% quantile (0.0016%)] 58 (69.0) 134 (79.8) Ref. Ref.
　High carriage [≥80% quantile (0.0016%)] 26 (31.0) 34 (20.2) 1.94 (1.01−3.71) 4.64 (1.73−12.50)
Fusobacterium nucleatum
　Low carriage [<30% quantile (0.5956%)] 9 (10.7) 51 (30,4) Ref. Ref.
　High carriage [≥30% quantile (0.5956%)] 75 (89.3) 117 (69.6) 5.64 (2.13−14.88) 3.85 (1.12−13.24)
Lachnoanaerobaculum umeaense
　Low carriage [< 95% quantile (0.4933%)] 67 (79.8) 159 (94.6) Ref. Ref.
　High carriage [≥95% quantile (0.4933%)] 17 (20.2) 9 (5.4) 6.75 (2.24−20.41) 10.93 (2.24−53.38)
Leptotrichia hofstadii
　Low carriage [<35% quantile (0.0782%)] 11 (13,1) 59 (35.1) Ref. Ref.
　High carriage [≥35% quantile (0.0782%)] 73 (86.9) 109 (64.9) 3.65 (1.77−7.50) 2.36 (0.89−6.25)
Prevotella baroniae
　Low carriage [<60% quantile (0.0051%)] 37 (44.0) 101 (60.1) Ref. Ref.
　High carriage [≥60% quantile (0.0051%)] 47 (56.0) 67 (39.9) 2.15 (1.19−3.89) 1.98 (0.86−4.58)
Prevotella melaninogenica
　Low carriage [<30% quantile (0.1074%)] 10 (11.9) 51 (30.4) Ref. Ref.
　High carriage [≥30% quantile (0.1074%)] 74 (88.1) 117 (69.6) 4.79 (1.94−11.87) 3.26 (1.05−10.19)
Prevotella shahii
　Low carriage [<90% quantile (0.0446%)] 62 (73.8) 151 (89.9) Ref. Ref.
　High carriage [≥90% quantile (0.0446%)] 22 (26.2) 17 (10.1) 3.54 (1.65−7.63) 2.37 (0.81−6.90)
Rothia dentocariosa
　Low carriage [<70% quantile (0.1806%)] 47 (56.0) 117 (69.6) Ref. Ref.
　High carriage [≥70% quantile (0.1806%)] 37 (44.0) 51 (30.4) 2.04 (1.11−3.75) 2.66 (1.12−6.31)
OR, odds ratio; 95% CI, 95% confidence interval; Ref., reference category; SDA, severe dysplasia and above. *, The optimal cut-off
point for relative abundance of each predictive species was listed in the brackets; **, The analyzed dataset (full averaged dataset)
contained a total of 84 SDA cases providing 143 oral specimens and 168 matched controls providing 285 oral specimens. For all
specimens produced by each subject, bacterial abundance at the species level was averaged to produce a single value for that
subject; ***, OR and 95% CI were derived by univariate conditional logistic regression analysis and multivariate conditional logistic
regression analysis including all species listed in the Table as well as family history of esophageal cancer.
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sampling (average of overall  CVs=251.2%), resulting in an
average ratio of intra-individual CV and overall  CV of 0.4
(Figure  4; Supplementary  Table  S4),  and  no  appreciable
discrepancy was found in cases and controls.
Discussion
One of the key problems in current microbiome-oncology
research is the lack of prospective longitudinal studies, and
the execution of such studies within the microbiome field is
challenging  but  is  urgently  needed  to  provide  direct
evidence  of  causation  (18).  In  this  first  dynamic
longitudinal  investigation  of  the  causative  and  predictive
role  of  oral  microbiome  in  malignant  esophageal  lesions,
we  show  that  specific  oral  species  are  differentially
abundant  with  respect  to  disease  status,  and  a  panel  of  11
bacteria can accurately distinguish SDA cases from healthy
controls.  It  seems  likely  that  the  oral  microbiome  has  an
etiological  role  in  esophageal  cancer,  and it  holds  promise
as  a  non-invasive  early  warning  biomarker  for  risk
stratification  for  esophageal  cancer  screening  programs.
The  oral  microbiome  presents  an  opportunity  to  better
understand  esophageal  cancer  and  how  it  might  be
prevented.
 
Figure 3 Performance of oral microbiome-based prediction model using the optimal cut-off point for risk of malignant esophageal lesions
in  Anyang,  China,  2006−2017.  The  predictive  model  included  11  oral  species  and  family  history  of  esophageal  cancer.  ROC  for  this
prediction model constructed based on (A) full averaged dataset [AUC: 0.89 (95% CI, 0.84−0.93)]; (B) strictly averaged dataset [AUC: 0.85
(95%  CI,  0.80−0.91)];  (C)  full  baseline  dataset  [AUC:  0.84  (95%  CI,  0.79−0.89)];  (D)  strict  baseline  dataset  [AUC:  0.85  (95%  CI,
0.79−0.91)]. For A and B datasets, and for all specimens produced by each subject, bacterial abundance at the species level was averaged to
produce  a  single  value  for  that  subject.  AUC,  area  under  the  receiver  operating  characteristic  curve;  95%  CI,  95%  confidence  interval;
ROC, receiver operating characteristic; SDA, severe dysplasia and above.
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Cross-sectional  studies  and case-control  studies  have
reported  distinct  differences  in  upper  digestive  tract
microbiome between gastroesophageal reflux disease (19-
21),  Barrett’s  esophagus  (19-22),  esophageal  adeno-
carcinoma (EAC) (19,23), esophageal squamous dysplasia
(24), or ESCC (6,7,9) cases and controls. Additionally, poor
oral health, including poor periodontal health, tooth loss,
and irregular teeth brushing, has repeatedly reported to be
linked  with  the  risk  of  malignant  esophageal  lesions
(2,6,7,25,26), supporting the hypothesis that oral health-
related microbial environment (e.g. oral dysbiosis) may play
a  role  in  the  carcinogenesis  of  esophageal  epithelium.
However,  only  one  study  to  date  has  prospectively
examined  whether  upper  digestive  tract  microbiome
influences  risk  for  subsequent  esophageal  cancer.  In  a
nested  case-control  study  conducted  in  USA,  Peters
et  al.  evaluated  oral  bacteria  using  16S  rRNA  gene
sequencing in prediagnostic mouthwash specimens from
n=81/160 EAC and n=25/50 ESCC cases/matched controls
(7). They found that several specific species were associated
with  cancer  risk  (For  EAC,  Tannerella  forsythia  and
Streptococcus  pneumoniae  with  P<0.05;  For  ESCC,
Prophyromonas gingivalis  with a P value of 0.09). In our
study, at  the species level,  we found that dozens of oral
bacteria were associated with malignant esophageal lesions.
Using  a  larger  sample  size  and  a  more  appropriate
statistical  method for abundance comparison (Deseq vs.
Conditional logistic regression) may partially explain the
larger  number  of  cancer  related-species  we found.  Our
results are in keeping with the current concept that mixed
communities  of  pathogens  collectively  drive  disease
progression,  rather  than  individual  species  working  in
isolation (13,27). The molecular mechanisms by which the
microbiome may be involved in the aetiopathogenesis of
cancer have been extensively discussed. All the proposed
mechanisms, including genomic integration, genotoxicity,
inflammation,  immunity  and  metabolism,  seem  to
ultimately  converge  on  final  common  pathways  of
enhanced capacity of replication and dedifferentiation, and
prolonged host cell survival (18). Further study about the
oncogenic  mechanisms  by  which  the  oral  microbiome,
alone or alongside with environmental  and host factors,
may initiate and/or drive the carcinogenesis of esophageal
cancer is warranted.
All 11 SDA lesion-associated oral species included in this
prediction model were anaerobic bacteria. Four of these
(Actinomyces  odontolyticus ,  Actinomyces  viscosus ,
Lachnoanaerobaculum umeaense, and Rothia dentocariosa)
were  Gram-positive,  and  all  the  others  were  Gram-
negative. For the most part, these bacteria live in harmony
with the host, generally in a commensal state. However,
under certain circumstances, this commensal relationship
may break down, and these bacteria may be involved in
human disease. While most of these 11 bacteria have been
reported  to  have  associations  with  dental  cavities  and
periodontal diseases, some have a linkage with autoimmune
diseases  (e.g.,  Lachnoanaerobaculum  umeaense  induces
animal models of celiac disease), and some are correlated
with  cancer  (e.g.,  Prevotella  melaninogenica  shows
increased abundance in oral cancer patients) (28,29).
Fusobacterium nucleatum  is  a  well-known periodontal
pathogen  identified  as  one  bacterium  among  these  11
 
Figure  4 Intra-individual  CVs  and  overall  CVs  for  predictive  oral  species  in  subjects  with  multiple  sampling  from  Anyang,  China,
2006−2017.  A  total  of  28  subjects  (C)  including  (A)  10  SDA  cases  and  (B)  18  controls  (each  with  three  or  more  serial  specimens)  were
included  in  this  analysis.  For  each  predictive  species,  CVs  for  each  individual  were  calculated  based  on  the  relative  abundance  of  all
specimens from this individual. Mean CV (intra-individual CV) was the mean of all CVs calculated from all included individuals. Overall
CV was calculated based on the relative abundances from all specimens provided by all included individuals. AVG, average; CV, coefficient
of  variation;  SDA,  severe  dysplasia  and  above;  Ao, Actinomyces  odontolyticus;  Av, Actinomyces  viscosus;  Di, Dialister  invisus;  Fm,
Fusobacterium  mortiferum;  Fn, Fusobacterium  nucleatum;  Lu, Lachnoanaerobaculum  umeaense;  Lh, Leptotrichia  hofstadii;  Pb, Prevotella
baroniae; Pm, Prevotella melaninogenica;Ps, Prevotella shahii; Rd, Rothia dentocariosa.
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predictive bacteria (17). This bacterium has frequently been
found to be enriched in colorectal cancer tissues, and it has
been suggested that it influences colorectal carcinogenesis
through activation of cellular proliferation pathways, and
by suppression of  the antitumor immune response (30).
Given the proximity of the esophagus to the oral cavity,
Fusobacterium nucleatum may also play a role in esophageal
cancer. Using real-time polymerase chain reaction (PCR),
Yamamura et al. reported that 23% of ESCC tumor tissues
contain Fusobacterium nucleatum  DNA, which is greater
than that in normal adjacent esophageal tissue (P=0.021).
Moreover  the  presence  of  Fusobacterium  nucleatum  is
associated  with  significantly  shorter  survival  time  in
patients with ESCC (17). Prophyromonas gingivalis has also
been found to be associated with ESCC (6,31) but we did
not observe a significant difference in its relative abundance
in cases of malignant esophageal lesions and their matched
controls in our study population. One possible explanation
is  that  these  studies  assessed  for  the  presence  of
Prophyromonas  gingivalis  rather  than  its  relative
abundance. A recent report from a study also conducted in
Henan,  China  supported  our  findings  (32).  This  study
showed  that  tumor  tissues  had  a  greater  abundance  of
Fusobacterium than paired non-tumor tissues (67 pairs), but
no  s igni f icant  d i f ference  in  the  abundance  of
Porphyromonas  was  observed.  Altogether,  certain  oral
bacterial species, including Fusobacterium nucleatum, might
contribute to and predict the carcinogenesis of malignant
esophageal  lesions.  Identification  and  manipulation  of
carcinogenic oral bacteria may offer actionable strategies
for prevention of this highly fatal disease.
Sensitivity analysis of the performance of this predictive
model showed that after excluding cases diagnosed within 1
year  of  collection  of  the  baseline  specimen  and  their
matched  controls,  the  AUC  remained  high.  More
importantly,  this  model  performed  well  for  both
endoscopically  screened  and  clinically  diagnosed  case-
control triads. Identification of early esophageal lesions is a
primary concern of endoscopic screening, as early lesions
are of greater clinical and public-health importance than
clinically  diagnosed  SDA  cases.  Most  of  the  latter  are
advanced  lesions  which  are  less  likely  to  benefit  from
treatment (33). When analysis was limited to the baseline
data  of  the  AECCS cohort,  the  final  prediction  model
stably yielded good discriminatory results. Additionally, we
found that the overall  CV across all  specimens from all
individuals  with  multiple  sampling was  about  2.3  times
higher than the intra-individual CV (251.2% vs. 107.9%),
indicating the time-stability of these species. Consistent
with our findings, previous studies have also suggested that
the abundance of core members of the oral microbiome is
fairly stable over time, although more precise microbiome
estimates can be obtained by measurement at multiple time
points (34,35). These findings indicate our model may also
be  generalized  in  settings  without  intensive  sampling,
where single-time only specimen collection is employed.
Altogether, the oral microbiome holds promise as a non-
invasive early warning biomarker for risk stratification for
esophageal cancer screening programs.
Due  to  the  high  incidence  of  ESCC  in  China,
endoscopic surveillance of esophageal cancer has come to
be  viewed  as  an  important  national  undertaking.  Since
2006, more than 1 million endoscopies sponsored by the
Chinese  government  have  been  carried  out  in  several
regions  of  high  ESCC  incidence  (36,37).  The  cost  of
endoscopic  examination  is  high,  and  endoscopy  is  an
invasive procedure. Therefore, identification of high-risk
subjects in the general  population is  a strategy which is
cost-effective.  We previously established an easy-to-use
risk prediction model for ESCC using demographic and
lifestyle factors (37). Use of the model in screening could
have allowed 27% of subjects 60 years or younger and 9%
of subjects older than 60 years to avoid endoscopy without
missing SDAs, which means that approximately 16.6% of
endoscopies  in  total  could  have  been  avoided.  Oral
microbiome markers could be combined in the future with
demographic/lifestyle  factors  to  construct  a  more
comprehensive  and  accurate  prediction  model  for
malignant  esophageal  lesions.  Incorporation  of  model-
based risk assessment into large-scale screening programs
for esophageal cancer with endoscopic examination of only
high-risk individuals identified by the model may render
screening programs safer and more cost-effective.
Although this is the first population-based nested case-
control study with multiple sampling, its limitations should
be  noted.  First,  due  to  the  prospective  matched  case-
control  design,  the  added  predictive  value  of  matching
factors such as age could not be evaluated. Second, despite
access to a repository of >40,000 oral specimens from the
AECCS cohort, the absolute number of case-control triads
included in this  study with multiple specimens was still
relatively small due to the low incidence of SDA lesions
which rendered some temporal analysis inaccurate. Third,
an independent external cohort is needed to validate the
results of this study.
Conclusions
This prospective study shows that specific members of the
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oral microbiome are associated with the subsequent risk of
malignant  esophageal  lesions,  and  a  model  based  upon  a
panel of 11 lesion-associated oral species achieves excellent
classification  performance.  This  lends  support  to  the
hypothesis  that  the  oral  microbiome  may  play  a  causative
and  predictive  role  in  the  aetiopathogenesis  of  esophageal
cancer,  and  raises  the  possibility  that  the  non-invasive
microbiome  biomarkers,  alone  or  in  combination  with
other  factors,  may  enable  risk-stratification  of  esophageal
cancer screening programs in the future. Our findings have
implications  for  a  personalized  approach  to  primary  and
secondary prevention of esophageal cancer. Further studies
are  needed  to  validate  our  findings  and  to  elucidate
mechanisms of the causal relationship.
Acknowledgements
This work was supported by the National Natural Science
Foundation of China (No. 30930102, 82073626, 81502855,
81773501), the National Key R&D program of China (No.
2016YFC0901404),  the  National  Special  Programme  of
Scientific  and  Technological  Resources  Investigation  (No.
2019FY101102),  the  Digestive  Medical  Coordinated
Development  Center  of  Beijing  Hospitals  Authority  (No.
XXZ0204),  the  Beijing  Natural  Science  Foundation  (No.
7182033),  the  Beijing  Municipal  Administration  of
Hospital’s  Youth  Programme  (No.  QML20171101),  and
the  Science  Foundation  of  Peking  University  Cancer
Hospital (No. 2020-7).
Footnote
Conflicts  of  Interest:  The  authors  have  no  conflicts  of
interest to declare.
References
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer
statistics 2018: GLOBOCAN estimates of incidence
and  mortality  worldwide  for  36  cancers  in  185
countries. CA Cancer J Clin 2018;68:394-424.
1.
Abnet  CC,  Arnold M, Wei  WQ. Epidemiology of
esophageal squamous cell carcinoma. Gastroenterology
2018;154:360-73.
2.
Codipilly DC, Qin Y, Dawsey SM, et al. Screening
for  esophageal  squamous  cell  carcinoma:  recent
advances. Gastrointest Endosc 2018;88:413-26.
3.
Flemer B, Warren RD, Barrett MP, et al. The oral
microbiota  in  colorectal  cancer  is  distinctive  and
predictive. Gut 2018;67:1454-63.
4.
Gilbert JA, Blaser MJ, Caporaso JG, et al.  Current
understanding of the human microbiome. Nat Med
2018;24:392-400.
5.
Yuan X, Liu Y, Kong J, et al. Different frequencies of
Porphyromonas gingivalis infection in cancers of the
upper digestive tract. Cancer Lett 2017;404:1-7.
6.
Peters  BA,  Wu  J,  Pei  Z,  et  al.  Oral  microbiome
composition reflects prospective risk for esophageal
cancers. Cancer Res 2017;77:6777-87.
7.
Ajayi  TA,  Cantrell  S,  Spann  A,  et  al.  Barrett’s
esophagus and esophageal cancer: Links to microbes
and the microbiome. PLoS Pathog 2018;14:e1007384.
8.
Chen X, Winckler B, Lu M, et al.  Oral microbiota
and risk for esophageal squamous cell carcinoma in a
high-risk area of China. PLoS One 2015;10:e0143603.
9.
Liu F, Guo F, Zhou Y, et al. The Anyang esophageal
cancer cohort study: study design, implementation of
fieldwork, and use of computer-aided survey system.
PLoS One 2012;7:e31602.
10.
Zhang C, Liu F, Pan Y, et al. Incidence and clearance
of oral human papillomavirus infection: A population-
based cohort study in rural China. Oncotarget 2017;
8:59831-44.
11.
Schemper  M,  Smith  TL.  A  note  on  quantifying
follow-up  in  studies  of  failure  time.  Control  Clin
Trials 1996;17:343-6.
12.
Hayes RB, Ahn J,  Fan X, et  al.  Association of  oral
microbiome  with  risk  for  incident  head  and  neck
squamous cell cancer. JAMA Oncol 2018;4:358-65.
13.
Love MI, Huber W, Anders S. Moderated estimation
of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol 2014;15:550.
14.
Winer RL, Kiviat NB, Hughes JP, et al. Development
and duration of human papillomavirus lesions, after
initial infection. J Infect Dis 2005;191:731-8.
15.
Griffen AL, Beall CJ, Campbell JH, et al. Distinct and
complex bacterial profiles in human periodontitis and
health revealed by 16S pyrosequencing. ISME J 2012;
6:1176-85.
16.
Yamamura  K,  Baba  Y,  Nakagawa  S,  et  al.  Human
microbiome Fusobacterium nucleatum in esophageal
cancer tissue is associated with prognosis. Clin Cancer
Res 2016;22:5574-81.
17.
Scott  AJ,  Alexander  JL,  Merrifield  CA,  et  al.
International  Cancer  Microbiome  Consortium
consensus statement on the role of the human micro-
biome in carcinogenesis. Gut 2019;68:1624-32.
18.
Blackett KL, Siddhi SS, Cleary S, et al. Oesophageal
bacterial biofilm changes in gastro-oesophageal reflux
19.
Chinese Journal of Cancer Research, Vol 32, No 6 December 2020 753
© Chinese Journal of Cancer Research. All rights reserved. www.cjcrcn.org Chin J Cancer Res 2020;32(6):742-754
disease,  Barrett’s  and  oesophageal  carcinoma:
association  or  causality?  Aliment  Pharmacol  Ther
2013;37:1084-92.
Yang L, Lu X, Nossa CW, et al. Inflammation and
intestinal  metaplasia  of  the  distal  esophagus  are
associated  with  alterations  in  the  microbiome.
Gastroenterology 2009;137:588-97.
20.
Liu N, Ando T, Ishiguro K, et al. Characterization of
bacterial  biota  in  the  distal  esophagus  of  Japanese
patients  with  reflux  esophagitis  and  Barrett’s
esophagus. BMC Infect Dis 2013;13:130.
21.
Macfarlane  S,  Furrie  E,  Macfarlane  GT,  et  al.
Microbial colonization of the upper gastrointestinal
tract in patients with Barrett’s esophagus. Clin Infect
Dis 2007;45:29-38.
22.
Zaidi AH, Kelly LA, Kreft RE, et al. Associations of
microbiota and toll-like receptor signaling pathway in
esophageal  adenocarcinoma.  BMC  Cancer  2016;
16:52.
23.
Yu  G,  Gail  MH,  Shi  J,  et  al.  Association  between
upper  digestive  tract  microbiota  and  cancer-
predisposing  states  in  the  esophagus  and stomach.
Cancer Epidemiol Biomarkers Prev 2014;23:735-41.
24.
Di  Pilato  V,  Freschi  G,  Ringressi  MN,  et  al.  The
esophageal microbiota in health and disease. Ann N Y
Acad Sci 2016;1381:21-33.
25.
Nwizu  NN,  Marshall  JR,  Moysich  K,  et  al .
Periodontal disease and incident cancer risk among
postmenopausal  women:  results  from the women’s
health  initiative  observational  cohort.  Cancer
Epidemiol Biomarkers Prev 2017;26:1255-65.
26.
Jakubovics NS, Yassin SA, Rickard AH. Community
interactions of oral streptococci. Adv Appl Microbiol
2014;87:43-110.
27.
Mager  DL,  Haffajee  AD,  Devlin  PM,  et  al.  The
salivary microbiota as a diagnostic indicator of oral
cancer:  a  descriptive,  non-randomized  study  of
28.
cancer-free  and  oral  squamous  cell  carcinoma
subjects. J Transl Med 2005;3:27.
Lerner  A,  Aminov  R,  Matthias  T.  Dysbiosis  may
trigger autoimmune diseases via inappropriate post-
translational  modification  of  host  proteins.  Front
Microbiol 2016;7:84.
29.
Sato  Y,  Yamagishi  J,  Yamashita  R,  et  al.  Inter-
individual  differences  in  the  oral  bacteriome  are
greater  than  intra-day  fluctuations  in  individuals.
PLoS One 2015;10:e0131607.
30.
Gao S, Li S, Ma Z, et al. Presence of Porphyromonas
gingivalis  in esophagus and its association with the
clinicopathological  characteristics  and  survival  in
patients with esophageal cancer. Infect Agent Cancer
2016;11:3.
31.
Shao  D,  Vogtmann  E,  Liu  A,  et  al.  Microbial
characterization  of  esophageal  squamous  cell
carcinoma and gastric cardia adenocarcinoma from a
high-risk  region of  China.  Cancer  2019;125:3993-
4002.
32.
Pennathur  A,  Gibson  MK,  Jobe  BA,  et  a l .
Oesophageal carcinoma. Lancet 2013;381:400-12.
33.
Costello EK, Lauber CL, Hamady M, et al. Bacterial
community variation in human body habitats across
space and time. Science 2009;326:1694-7.
34.
Wang  J,  Jia  Z,  Zhang  B,  et  al.  Tracing  the
accumulation  of  in  vivo  human  oral  microbiota
elucidates  microbial  community  dynamics  at  the
gateway to the GI tract. Gut 2020;69:1355-6.
35.
Zhao  P,  Dai  M,  Chen  W,  et  al.  Cancer  trends  in
China. Jpn J Clin Oncol 2010;40:281-5.
36.
Liu  M,  Liu  Z,  Cai  H,  et  al.  A  model  to  identify
individuals at high risk for esophageal squamous cell
carcinoma and precancerous lesions in regions of high
prevalence  in  China.  Clin  Gastroenterol  Hepatol
2017;15:1538-46.e7.
37.
Cite this article as: Liu F, Liu M, Liu Y, Guo C, Zhou Y, Li F,
Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X,
Hu Z, Bao H, Cai H, Dos Santos Silva I, He Z, Ke Y. Oral
microbiome and risk of  malignant esophageal  lesions in a
high-risk area of China: A nested case-control study. Chin J
Cancer Res 2020;32(6):742-754. doi:10.21147/j.issn.1000-
9604.2020.06.07
754 Liu et al. Oral microbiome and malignant esophageal lesions
© Chinese Journal of Cancer Research. All rights reserved. www.cjcrcn.org Chin J Cancer Res 2020;32(6):742-754
 
 
Figure S1 Rarefaction curves of OTU number. The analysis was based on 84 SDA cases (providing 143 oral specimens) and 168 matched
controls (providing 285 oral specimens). OTU, operational taxonomic unit; SDA, severe dysplasia and above.
 
Figure S2 Species accumulation boxplot of observed species. The analysis was based on 428 oral specimens provided from 84 SDA cases
and 168 matched controls. SDA, severe dysplasia and above.
 
Figure  S3 Flowchart  for  selecting  oral  species  included  in  the  final  oral  microbiome-based  prediction  model  for  risk  of  malignant
esophageal  lesions  in  Anyang,  China,  2006−2017.  AIC,  Akaike  information  criterion;  DNA,  deoxyribonucleic  acid;  eHOMD,  expanded
Human Oral Microbiome Database; FDR, false discovery rate; OR, odds ratio; OTU, operational taxonomic unit; rRNA, ribosomal RNA;
SDA, severe dysplasia and above.
 
 
Figure S4 α diversity and β diversity  according to  years  of  oral  specimen collection before  diagnosis  of  malignant  esophageal  lesions  by
case-control status.  Trends  of  α diversity  (Shannon  index)  with  years  of  specimen  collection  prior  to  diagnosis  of  SDA  lesions  were
evaluated using linear mixed-effects (LME) regression (blue lines, shading indicates 95% CI). No significant trend was found for SDA cases
(P=0.124)  (A)  or  controls  (P=0.425)  (B).  Between  groups,  cases  showed  a  higher  Shannon  diversity  index  than  controls  (P=0.044);
PERMANOVA models  showed  that  SDA cases  differed  significantly  from controls  in  overall  oral  microbiome  composition  (β diversity)
neither  when  measured  by  unweighted  (P=0.248)  (C)  nor  when  measured  by  weighted  UniFrac  distances  (P=0.590)  (D).  95%  CI,  95%




Figure  S5 Performance  of  oral  microbiome-based  model  for  prediction  risk  of  malignant  esophageal  lesions  stratified  by  case  type  in
Anyang, China, 2006−2017. (A) ROC based on 52 screen-endoscopic-detected SDA cases (providing 84 oral specimens) and 104 matched
controls (providing 162 oral specimens) [AUC: 0.90 (95% CI, 0.86−0.95)]; (B) ROC based on 32 clinically diagnosed SDA cases (providing
59 oral  specimens)  and 64  matched controls  (providing  123 oral  specimens)  [AUC:  0.88  (95% CI,  0.81−0.94)].  ROC,  receiver  operating
characteristic;  SDA,  severe  dysplasia  and  above;  AUC,  area  under  the  receiver  operating  characteristic  curve;  95%  CI,  95%  confidence
interval; ESCC, esophageal squamous cell carcinoma.
 
 
Figure S6 Performance of oral microbiome-based prediction model using the 75th quantile cut-off point for risk of malignant esophageal
lesions  in  Anyang,  China,  2006−2017.  ROC  for  the  prediction  model  based  on  (A)  full  averaged  dataset  (84  SDA  cases  +  168  matched
controls)  [AUC:  0.78  (95%  CI,  0.72−0.83)];  (B)  strictly  averaged  dataset  (55  cases  +  110  matched  controls)  [AUC:  0.81  (95%  CI,
0.74−0.88)];  (C)  full  baseline  dataset  (84  cases  +  168  matched  controls)  [AUC:  0.78  (95% CI,  0.72−0.84)];  (D)  strict  baseline  dataset  (55
cases + 110 matched controls) [AUC: 0.82 (95% CI, 0.76−0.89)]; (E) 52 screen-endoscopic-detected SDA cases and 104 matched controls
[AUC: 0.81 (95% CI, 0.75−0.88)]; (F) 32 clinically diagnosed SDA cases and 64 matched controls [AUC: 0.84 (95% CI, 0.77−0.92)]. ROC,
receiver operating characteristic;  SDA, severe dysplasia and above;  AUC, area under the receiver operating characteristic  curve;  95% CI,
95% confidence interval.
Table S1 Number of filtered sequence reads per specimen*
Cross-sections
Total (N=428 specimens) Cases (N=143 specimens)** Controls (N=285 specimens)**
n Reads ( ) n Reads ( ) n Reads ( )
1 243 76,104±10,786 81 76,285±10,730 162 76,013±10,846
2 109 78,327±9,729 38 78,198±8,970 71 78,396±10,174
3 20 77,439±14,943 7 84,419±21,085 13 73,680±9,356
4 12 79,233±7,502 4 83,016±5,076 8 77,342±8,071
5 12 77,158±8,048 4 82,153±3,490 8 74,660±8,670
6 10 77,583±9,607 2 71,930±11,659 8 78,996±9,372
7 7 74,729±5,573 2 76,054±5,862 5 74,200±6,064
8 15 77,513±8,925 5 73,569±9,946 10 79,486±8,184
Total 428 76,911±10,444 143 77,385±10,733 285 76,673±10,306
*, Quality filtering on the raw reads was performed under specific filtering conditions to obtain the high-quality clean reads according
to the Cutadapt (Version 1.9.1, http://cutadapt.readthedocs.io/en/stable/) quality control process. The UCHIME algorithm (UCHIME
Algorithm, http://www.drive5.com/usearch/manual/uchime_algo.html)  was used to detect chimera sequences, and then the
chimera sequences were removed. Finally, clean reads were obtained. **, Cases were subjects with esophageal lesions of severe
dysplasia and above including severe squamous dysplasia, carcinoma in situ, and esophageal squamous cell carcinoma. Controls
were subjects without SDA lesions.
 
Figure  S7 Distribution  of  relative  abundance  of  predictive  species  among  individuals  with  four  or  more  specimens  in  Anyang,  China,
2006−2017. A total of 86 specimens provided from 4 SDA cases and 10 controls (with four or more serial specimens) were included in this
analysis. For each predictive species, the mean relative abundance, calculated across four or more specimens for each individual, is marked
by  the  dark  line.  SDA,  severe  dysplasia  and  above;  Ao, Actinomyces  odontolyticus;  Av, Actinomyces  viscosus;  Di, Dialister  invisus;  Fm,
Fusobacterium  mortiferum;  Fn, Fusobacterium  nucleatum;  Lu, Lachnoanaerobaculum  umeaense;  Lh, Leptotrichia  hofstadii;  Pb, Prevotella
baroniae; Pm, Prevotella melaninogenica; Ps, Prevotella shahii; Rd, Rothia dentocariosa.
 




1st quantile Median 3rd quantile
Shannon 0.80 1.82 1.94 3.70
Observed-species 2.21 2.94 5.00 6.57
CV, coefficients of variation; DNA, deoxyribonucleic acid; *, Indices were calculated with QIIME (Version1.7.0).
 
Table S3 Species with differential abundance in cases of malignant esophageal lesions and controls based on DESeq analysis in Anyang,
China, 2006−2017
Species* baseMean** log2 (fold change)±SE P*** Q****
Actinomyces naeslundii 278.57 0.75±0.21 <0.001 0.006
Actinomyces odontolyticus 149.37 0.40±0.17 0.022 0.100
Actinomyces radicidentis 31.02 0.58±0.21 0.007 0.049
Actinomyces viscosus 336.96 0.59±0.19 0.002 0.022
Alloprevotella rava 20.51 0.57±0.21 0.006 0.048
Alloprevotella tannerae 32.72 0.50±0.20 0.011 0.061
Bosea robiniae 111.12 −0.66±0.23 0.004 0.037
Campylobacter concisus 101.78 0.70±0.19 <0.001 0.005
Caulobacter vibrioides 697.47 −0.55±0.24 0.022 0.100
Corynebacterium durum 42.36 0.57±0.21 0.007 0.049
Corynebacterium matruchotii 303.41 0.91±0.22 <0.001 0.001
Dialister invisus 73.40 0.79±0.22 <0.001 0.006
Fusobacterium mortiferum 24.39 0.64±0.24 0.009 0.057
Fusobacterium nucleatum 1,358.57 0.53±0.16 0.001 0.015
Fusobacterium simiae 278.13 0.91±0.26 0.001 0.009
Lachnoanaerobaculum umeaense 151.14 0.54±0.17 0.001 0.015
Leptotrichia buccalis 693.34 0.82±0.23 <0.001 0.005
Leptotrichia hofstadii 297.77 0.93±0.22 <0.001 0.001
Leptotrichia hongkongensis 381.05 0.71±0.22 0.001 0.013
Leptotrichia shahii 50.77 0.53±0.22 0.015 0.082
Neisseria flavescens|subflava 722.49 0.49±0.21 0.020 0.099
Prevotella baroniae 13.11 0.74±0.22 0.001 0.008
Prevotella intermedia 227.10 0.54±0.23 0.022 0.100
Prevotella maculosa 27.34 0.45±0.19 0.020 0.099
Prevotella melaninogenica 699.20 0.49±0.21 0.021 0.099
Prevotella micans 12.19 0.87±0.22 <0.001 0.003
Prevotella oulorum 58.03 0.50±0.22 0.023 0.100
Prevotella pallens 133.88 0.54±0.22 0.014 0.076
Prevotella saccharolytica 24.58 0.78±0.21 <0.001 0.005
Prevotella shahii 16.42 0.77±0.19 <0.001 0.001
Pseudomonas toyotomiensis 34.37 −0.59±0.23 0.010 0.061
Pseudopropionibacterium propionicum 136.13 0.59±0.23 0.011 0.061
Rothia dentocariosa 164.18 0.59±0.21 0.005 0.040
Selenomonas dianae 21.72 0.60±0.21 0.005 0.040
Selenomonas sputigena 62.57 0.46±0.20 0.022 0.100
Treponema socranskii 58.19 0.73±0.22 0.001 0.013
Treponema vincentii 44.34 0.61±0.23 0.008 0.053
FDR, false discovery rate; SDA, severe dysplasia and above; SE, standard error. *, A total of 84 SDA cases providing 143 oral
specimens and 168 matched controls providing 285 oral specimens were included in this analysis. For all specimens produced by
each subject, bacterial abundance at each taxonomic level were averaged to produce a single value for that subject. All named and
cultured species with a FDR-adjusted Q<0.10 are included in the Table; **, “baseMean” is the average of normalized count values,
dividing by DESeq size factors, taken over all samples; ***, P values were obtained by using differential gene expression analysis
based on the negative binomial distribution (DESeq) in the DESeq2 package, adjusting for education level, type of employment,
cigarette smoking, alcohol consumption, and family history of esophageal cancer; ****, FDR-adjusted P value, the FDR adjustment
was conducted at the species level.




Ao Av Di Fm Fn Lu Lh Pb Pm Ps Rd
Control 75.1
M 362.2 1,336.7 6.0 0 3,328.9 81.0 54.1 0 4,882.2 21.2 1,343.0
CV 68.9 107.2 57.7 0 154.1 33.7 129.5 0 66.4 166.4 84.6
Control 75.2
M 164.8 1,256.2 3.6 0 155.2 100.8 336.6 0 1,286.2 12.5 386.2
CV 89.6 68.3 129.1 0 63.4 81.1 85.3 0 68.5 101.1 82.7
Control 76.2
M 220.6 150.6 50.9 2.6 1,480.4 195.7 705.4 0 132.5 32.2 172.2
CV 123.5 55.8 74.8 40.8 50.3 96.6 93.8 0 38.9 144.6 32.0
Control 77.1
M 301.9 1,527.1 7.9 0 1,055.6 189.5 185.0 12.5 480.3 12.8 121.1
CV 84.9 142.3 105.5 0 76.1 53.8 72.8 81.2 128.1 20.7 47.8
Control 77.2
M 38.9 545.5 7.0 0.6 986.4 124.9 1,329.1 2.3 174.1 6.0 300.8
CV 54.9 116.5 97.0 173.2 52.6 113.6 126.0 173.2 74.9 77.0 77.2
Control 78.1
M 54.2 13.6 6.1 0 469.8 117.8 195.1 2.3 129.3 22.3 20.3
CV 32.7 13.0 45.2 0 62.2 109.0 134.6 86.6 72.7 106.7 73.4
Control 78.2
M 370.4 226.3 41.9 0 2,453.9 229.1 105.5 3.9 354.9 3.2 1,017.6
CV 123.1 31.0 144.1 0 90.6 76.6 43.5 88.1 91.4 173.2 48.0
Control 79.2
M 103.6 82.9 1.0 0 237.1 191.5 45.1 1.6 258.0 4.1 6.9
CV 60.3 159.4 173.2 0 136.3 150.4 170.0 97.3 142.8 139.7 45.5
Control 83.1
M 92.3 447.4 150.0 0.3 2,822.6 153.9 294.0 19.8 7,335.3 7.2 387.5
CV 68.1 102.6 79.6 244.9 138.6 118.8 87.2 185.3 105.7 192.3 85.9
Control 83.2
M 180.6 1,335.7 40.2 0 449.3 106.9 213.0 0 6,843.3 46.3 896.2
CV 66.7 69.6 153.7 0 58.2 55.9 125.8 0 73.2 90.4 111.5
Control 81.1
M 56.8 167.4 8.6 0 335.0 79.1 113.6 1.6 547.6 13.6 278.5
CV 32.1 200.5 111.9 0 78.0 116.6 167.8 127.0 189.5 133.5 223.1
Control 81.2
M 65.8 337.0 39.1 10.5 1,930.3 209.1 662.4 5.0 1,024.6 32.6 26.8
CV 81.8 213.4 131.9 215.0 97.9 81.6 124.5 122.6 132.6 72.0 70.0
Control 80.1
M 161.4 417.2 29.2 0 1,176.9 165.4 442.4 8.2 488.6 24.6 465.7
CV 183.7 83.6 86.8 0 108.0 93.6 85.0 109.3 127.9 86.2 103.2
Control 80.2
M 127.8 157.8 318.5 0.3 2,975.8 184.3 637.6 64.2 1,492.4 29.8 179.4
CV 40.2 132.9 95.9 200.0 78.2 88.5 76.5 114.5 93.6 172.5 137.9
Control 82.1
M 335.0 177.5 276.6 0 4,274.8 319.8 794.1 52.8 4,371.6 35.7 105.4
CV 159.4 140.3 129.1 0 101.4 34.7 111.2 118.1 169.0 149.1 134.5
Control 82.2
M 97.5 77.4 43.2 0 2,076.1 179.6 1,057.6 35.3 561.0 44.3 119.6
CV 81.3 98.6 110.1 0 66.8 61.2 143.5 76.7 74.0 120.2 102.1
Control 84.1
M 234.5 1,003.5 44.3 0.2 1,343.0 294.0 219.2 26.0 2,756.1 38.3 326.3
CV 108.0 109.6 102.6 282.8 56.1 116.8 90.4 108.0 112.3 102.3 133.7
Control 84.2
M 179.0 131.7 89.0 0.2 1,544.2 125.4 228.4 43.6 1,378.8 18.5 120.9
CV 47.3 45.5 79.3 264.6 75.9 77.5 115.2 74.0 79.5 131.5 42.1
Case 75
M 175.1 64.0 112.8 0 2,263.2 417.4 1,302.4 15.3 390.4 51.6 198.7
CV 88.4 63.0 104.2 0 58.0 104.2 96.8 46.3 67.2 110.2 108.9
Case 76
M 34.4 180.3 3.9 2,480.6 383.7 23.0 85.7 2.3 354.4 1.4 2,446.7







Ao Av Di Fm Fn Lu Lh Pb Pm Ps Rd
Case 77
M 852.8 541.3 180.0 0 1,586.6 212.1 114.6 13.7 487.5 16.4 613.3
CV 136.4 54.0 66.4 0 113.9 90.5 95.6 162.5 81.7 62.4 94.7
Case 78
M 141.3 686.2 74.3 1.1 3,618.8 235.2 810.7 10.8 300.2 81.9 537.8
CV 15.3 150.8 129.6 173.2 69.5 84.0 67.0 88.6 89.3 115.3 39.5
Case 79
M 440.2 230.2 485.5 0 3,054.4 440.0 866.8 0 2,318.6 24.2 93.2
CV 103.7 149.6 108.0 0 18.0 69.5 46.9 0 115.7 61.0 86.8
Case 83
M 122.8 176.3 39.6 0 2,034.8 118.4 107.5 11.7 7,76.3 11.4 157.3
CV 63.7 146.5 116.5 0 99.1 173.6 120.8 124.7 126.3 121.1 83.7
Case 81
M 321.7 2,070.1 45.3 1.6 937.0 344.9 269.9 0 6,127.9 19.7 372.4
CV 78.3 157.1 136.9 141.6 46.3 45.2 183.8 0 110.1 141.8 61.7
Case 80
M 547.7 69.5 284.1 0 1,790.1 569.6 1,316.7 7.1 864.5 65.0 62.6
CV 95.4 26.0 70.3 0 69.6 0.4 83.9 86.8 129.5 65.1 83.3
Case 82
M 254.2 647.4 33.1 0 1,817.2 186.1 735.1 56.4 1,887.3 34.7 425.2
CV 161.3 74.1 86.3 0 87.6 72.1 130.6 227.9 104.3 85.9 114.3
Case 84
M 84.8 121.4 26.7 4.1 1,253.7 122.3 340.0 6.6 237.2 76.4 70.2
CV 66.6 97.4 163.7 249.6 111.6 106.0 104.4 105.5 149.6 196.2 70.0
Controls
Overall M 171.0 496.2 75.4 0.9 1,721.7 177.8 437.7 19.4 2,255.9 25.3 320.6
Overall CV 132.9 160.2 201.3 660.5 132.0 95.1 160.5 176.5 177.8 133.4 160.5
Intra-individual CV 83.7 105.0 106.0 203.0 85.8 86.7 110.1 111.6 102.3 121.1 90.8
Cases
Overall M 259.6 503.1 100.3 174.0 1,783.7 237.6 520.5 14.3 1,469.9 38.2 415.4
Overall CV 155.7 242.4 185.4 651.7 88.0 96.7 134.0 339.8 201.0 182.2 188.4
Intra-individual CV 92.3 99.1 106.9 184.3 69.1 82.7 100.3 117.1 105.4 113.2 82.8
Total
Overall M 200.8 498.5 83.7 59.1 1,742.5 197.9 465.5 17.7 1,991.8 29.7 352.4
Overall CV 149.3 191.3 195.4 1,112.7 118.1 97.4 150.2 223.5 185.6 165.0 174.8
Intra-individual CV 86.8 102.9 106.3 196.2 79.8 85.3 106.6 113.6 103.4 118.3 88.0
M, mean relative abundance; CV, coefficient of variation; SDA, severe dysplasia and above; Ao, Actinomyces odontolyticus; Av,
Actinomyces viscosus; Di, Dialister invisus; Fm, Fusobacterium mortiferum; Fn, Fusobacterium nucleatum; Lu, Lachnoanaerobaculum
umeaense; Lh, Leptotrichia hofstadii; Pb, Prevotella baroniae; Pm, Prevotella melaninogenica; Ps, Prevotella shahii; Rd, Rothia
dentocariosa. *, Cases were subjects with esophageal lesions of severe dysplasia and above (SDA) including severe squamous
dysplasia, carcinoma in situ, and esophageal squamous cell carcinoma. Controls were subjects without SDA lesions. For each
predictive species (column), M and CV are listed. CV is presented as a percentage. In rows (i.e. Control 75.1), M and CV are
calculated based on the relative abundance of three or more specimens from the respective individual. M and CV rows with the
heading “Overall” were calculated from all specimens provided by included subjects (each with three or more serial specimens). The
intra-individual CV row is mean of all CVs calculated from all included individuals.
